ImmunoSkills: €3 Million to train the immunotherapy experts of tomorrow

Marseille, September 23, 2025 – The ImmunoSkills project, developed in partnership with the Marseille Immunology Biocluster (MIB), has been selected as a laureate of the “Compétences et Métiers d’Avenir” (CMA) call for expressions of interest under the France 2030 plan, securing €3 million in funding. Its goal is to establish a center of excellence in immunotechnologies in the Provence-Alpes-Côte d’Azur region.

As the global immunotherapy market is expected to exceed $170 billion by 2032, ImmunoSkills aims to train highly qualified professionals who will design the biopharmaceuticals of the future. The project offers comprehensive programs from the Baccalaureate to the Doctorate level, complemented by 31 continuing education modules for professionals and technicians. An international Graduate School will also be created to promote excellence and global engagement in academic pathways.

The Marseille Immunology Biocluster (MIB) plays a strategic role within ImmunoSkills, contributing its scientific expertise and extensive network of companies and research laboratories. Through MIB, the project bridges education, research, and innovation, ensuring that training programs are directly aligned with market needs and technological advances in the field.

ImmunoSkills brings together a robust network of academic, industrial, and institutional partners*, ensuring perfect alignment between training programs and the labor market’s evolving demands.
This initiative has been made possible through the France 2030 experimental framework implemented by the Région Sud, the Regional Secretariat for Regional Affairs (SGAR) Provence-Alpes-Côte d’Azur, the Regional Directorate for the Economy, Employment, Labor, and Solidarity (DREETS PACA), and the Academic Region.